VNDA ▼ -0.3% - Vanda Pharmaceuticals Inc.
$VNDA VNDA - Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting
27-OCT-2026 06:51 AM ET
Share this post
More filings for $VNDA
VNDA ▼ -2.4% - Vanda Pharmaceuticals Inc.Oct 21, 2026VNDA ▼ -10.9% - Vanda Pharmaceuticals Inc.Oct 14, 2026VNDA ▼ -10.9% - Vanda Pharmaceuticals Inc.Oct 14, 2026VNDA - Vanda Pharmaceuticals Inc. - SEC Filing Update (09-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 9, 2026VNDA ▲ +0.4% - Vanda Pharmaceuticals Inc.Oct 2, 2026VNDA ▲ +10.8% - Vanda Pharmaceuticals Inc.Sep 29, 2026
View full $VNDA filing history →💬 Comments
Loading comments…
Leave a comment